Biotech firm Phytome Life Sciences plans to establish a headquarters in Saudi Arabia in a bid to accelerate commercialization ...
Then in 2006, CAT was bought by AstraZeneca for £700 million, dashing hopes that the UK could produce a world-class biotech to rival the success of US companies Amgen and Genentech. This pattern ...
Hosted on MSN18d
BIA report: UK biotech investment surged to £3.5bn in 2024On public markets, UK biotech companies raised £1.5bn through follow-on financings – a 170% increase from 2023 – driven by firms listed on Nasdaq. However, for the second consecutive year ...
By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...
Moleculin Biotech (MBRX) has received first country regulatory approval in Europe to begin recruiting for its Phase 3 pivotal trial protocol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results